Dupilumab for the Treatment of Severe Atopic Dermatitis in an Immunosuppressed Transplant Patient

Dermatitis®Ahead of Print LettersDupilumab for the Treatment of Severe Atopic Dermatitis in an Immunosuppressed Transplant PatientAfsoon Ghafari-Saravi and Teri M. GreilingAfsoon Ghafari-Saravihttps://orcid.org/0000-0002-3660-2308Department of Dermatology, Oregon Health and Science University, Portland, OR, USA. Search for more papers by this authorEmail the corresponding author at [email protected] and Teri M. GreilingDepartment of Dermatology, Oregon Health and Science University, Portland, OR, USA.Search for more papers by this authorPublished Online:10 Aug 2023https://doi.org/10.1089/derm.2023.0181AboutSectionsView articleView Full TextSupplemental MaterialPDF/EPUBView Supplemental Data Permissions & CitationsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Dupilumab for the Treatment of Severe Atopic Dermatitis in an Immunosuppressed Transplant Patient." Dermatitis®, , pp. FiguresReferencesRelatedDetails Volume 0Issue 0 Information© 2023 American Contact Dermatitis Society. All Rights Reserved.To cite this article:Afsoon Ghafari-Saravi and Teri M. Greiling.Dupilumab for the Treatment of Severe Atopic Dermatitis in an Immunosuppressed Transplant Patient.Dermatitis®.ahead of printhttp://doi.org/10.1089/derm.2023.0181Online Ahead of Print:August 10, 2023PDF download